The Analytical Chemistry of Cannabis

Chemistry, Pharmacology, Manufacturing, Use, and Control of Medicinal Cannabis and Cannabinoid Dosage Formulations
2. Auflage 2026
ISBN: 978-0-443-23659-4
Verlag: Elsevier - Health Sciences Division

Buch, Englisch, 256 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Reihe: Emerging Issues in Analytical Chemistry

The Analytical Chemistry of Cannabis: Chemistry, Pharmacology, Manufacturing, Use, and Control of Medicinal Cannabis and Cannabinoid Dosage Formulations: Second Edition presents advanced methods in analytical chemistry to address modern issues surrounding cannabis-based products. Since the first edition, the cannabis industry has rapidly expanded its array of recreational and medicinal products. This volume provides crucial methods to support the manufacturing, labeling, and distribution of safe, consistent products with known chemical content and performance. It offers updated information on the chemistry and pharmacology of cannabis and cannabinoids and aims to resolve industry challenges by fostering understanding among scientists, public health officials, and non-scientist stakeholders.

The book is valuable for professionals in analytical chemistry, pharmacology, medicine, and law enforcement, as well as for advanced academic courses in related fields.

Autoren/Hrsg.

ElSohly, Mahmoud A.

Chandra, Suman

Fachgebiete

• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Naturwissenschaften Chemie Analytische Chemie

Inhaltsverzeichnis

Chapter 1 Introduction to cannabis, cannabinoids, and cannabimimetics

Chapter 2 The endocannabinoid signaling system

Chapter 3 Cannabis sativa L.: Botany, identification, propagation, and drug development

Chapter 4 Cannabis preparations and cannabinoid dosage forms

Chapter 5 Analysis of cannabinoids in cannabis and cannabinoid-containing dosage formulations

Chapter 6 Quality control and stability assessment

Chapter 7 In vitro bioanalytical methods for characterization of cannabinoid receptor interaction and cellular signaling response mechanisms

Chapter 8 Bioanalytical methods for analysis of endogenous cannabinoid receptor ligands

Chapter 9 Bioanalytical methods for quantitation of exogenous cannabinoid receptor ligands in biological fluids and pharmacokinetic/pharmacodynamic analysis

Chapter 10 The role of research and regulation in the therapeutic and recreational use of cannabinoids and cannabis in the future

Über Autor(innen)

Chandra, Suman
Dr. Suman Chandra earned his BS in Physical Sciences, MS in Physics, and MPhil in Environmental Plant Physiology with an emphasis on Biophysics from HNB Garhwal University. He completed his PhD in Plant Physiology at the High Altitude Plant Physiology Research Center, HNB Garhwal University. Dr. Chandra worked at the High Altitude Plant Physiology Research Center and the G.B. Pant National Institute of Himalayan Environment from 1992 to 2000. In 2001, he joined the University of Mississippi, where he currently serves as a Principal Scientist at the National Center for Natural Products Research and Research Professor of Biomolecular Sciences in the School of Pharmacy. He also serves as Co-Director of the NIDA Marijuana Project at the University of Mississippi. Dr. Chandra has over 25 years of experience in the field of cannabis and cannabinoid research and has authored or co-authored more than 100 publications and four scholarly books in the field. He also serves as the editorial board member of several scientific journals, including Frontiers in Plant Science, Scientific Reports, and Planta Medica.

ElSohly, Mahmoud A.
Mahmoud A. ElSohly is a Research Professor in National Center for Natural Products Research, Director of the Marijuana Project, and Professor of Pharmaceutics and Drug Delivery at the University of Mississippi. His Research has been continuously funded since 1981 by NIDA and other agencies. He holds more than 40 patents and has authored over 400 scholarly articles. He is also President and Laboratory Director of ElSohly Laboratories, Inc., a testing and drug development company in Oxford, Mississippi.